Home›Search›BMC Cancer

BMC Cancer

BioMed Central Ltd · United Kingdom · Est. 1838

ISSN1471-2407eISSN1471-2407

SJR Q2✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

100

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (4 more)+22

Total100

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

104

days submission → published

measured · last 20 articles · accept 88d

weeks to publish · journal-reported

Average · vs ~15 wk median

SJR Rank

Top 50% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei

1.172

H-Indexi

203

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.964

Total Worksi

20,248

Total Citationsi

608,011

2yr Mean Citednessi

3.24

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

BMC Cancer is an open access , peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1838

Annual Volume~ 1,661 articles / year

StatusActive (last: 2026)

Total Publications20,248

Publisher OrgBioMed Central

OA Since2000

Visit Journal Website

Submission Info

Peer ReviewOpen

Review Time~19 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

LOCKSSBritish Library; National Library of the NetherlandsPMC

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

BioMed Central Ltd

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1471-2407 / 1471-2407

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Open

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

LOCKSS, British Library; National Library of the Netherlands, PMC

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

1.3k

47k

2019

1.2k

33k

2020

1.4k

29k

2021

1.4k

22k

2022

1.3k

15k

2023

1.6k

11k

2024

2.1k

5.4k

2025

918

116

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cancer ResearchQ2

GeneticsQ2

OncologyQ2

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

GeneticsCancer ResearchOncology

Research Topics (OpenAlex)

Cancer Immunotherapy and BiomarkersFerroptosis and cancer prognosisBreast Cancer Treatment StudiesCancer survivorship and careGlobal Cancer Incidence and ScreeningCancer Cells and MetastasisHead and Neck Cancer StudiesLung Cancer Treatments and MutationsHepatocellular Carcinoma Treatment and PrognosisInflammatory Biomarkers in Disease Prognosis

Frequently asked questions about BMC Cancer

Is BMC Cancer a predatory journal?

PubScope has no integrity flags on record for BMC Cancer: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of BMC Cancer?

BMC Cancer is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 3.24.

Is BMC Cancer indexed in Scopus and Web of Science?

BMC Cancer is indexed in Web of Science, Scopus, DOAJ.